← Leaderboards
Christopher David Putnam
University Of California, San Diego
$993,339
Attributed
$3,139,888
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $639.5K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,139,888 · 1
By mechanism
R01$3,139,888 · 1
Top collaborators
- Richard D Kolodner5 shared
- Jean Y.J. Wang5 shared
- Olivier Harismendy1 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Sun Ha Choo$982,214
- Yuan Chen$18,343,172
- Andrew D Chisholm$11,607,483
- Prashant Mali$7,570,171
- Stephanie Irene Fraley$4,680,756
Others in their field
Other Emerging Leaders on “Chromosomal Rearrangement”
- Peter Ly · Ludwig Institute For Cancer Res Ltd$3,705,644
- Claudia Carvalho Fonseca · Baylor College Of Medicine$3,513,117
- Hong Wen · Van Andel Research Institute$3,004,575
- Laura K Conlin · Children'S Hosp Of Philadelphia$2,906,996
- Cheng-Zhong Zhang · Dana-Farber Cancer Inst$2,685,049
- Christopher John Tompkins · Kromatid, Inc.$2,579,745
Research focus
Chromosomal RearrangementAffectAntineoplastic AgentsAblationBase Excision RepairsBiological ModelsBrca1 GeneBrca1 MutationBrca2 GeneBrca2 MutationBrca GeneBreast Cancer Cell LineBreast Cancer TherapyCancer CellCancer Cell LineCancer GenomeCancer GenomicsCancer TherapyCancer TypeCandidate SelectionCandidate ValidationCell LineCellsChromosome Breakage
Grant awards (5)
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$639,488
R01 · FY2025 · CA
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$607,512
R01 · FY2024 · CA
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$626,700
R01 · FY2023 · CA
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$626,700
R01 · FY2022 · CA
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$639,488
R01 · FY2021 · CA